Literature DB >> 16455288

Efficacy of a novel lubricating system in the management of radiotherapy-related xerostomia.

Anne S McMillan1, C S Peter Tsang, May C M Wong, Andrew Y L Kam.   

Abstract

A comparison was made of Oral Balance gel delivered by slow release via a novel intra-oral device versus an oral bolus of gel on the oral health condition and oral health-related quality of life (OHRQoL) in patients who had received standard head and neck irradiation for nasopharyngeal carcinoma. Twenty-two participants took part in a randomized single-blind crossover clinical study. Each treatment lasted 4 weeks with an intervening 4 weeks washout period. The GOHAI, Xerostomia Inventory and patient satisfaction measures were self-completed and oral health condition assessed objectively at baseline (week 0) and weeks 4, 8 and 12. Oral Balance gel, in bolus and slow-release forms, was effective in improving aspects of oral health, notably a reduction in oral cariogenic micro-organisms. Slow release of gel via the intra-oral device did not appear to improve OHRQoL whereas gel alone reduced the severity of xerostomia symptoms and was the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455288     DOI: 10.1016/j.oraloncology.2005.12.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

1.  Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia.

Authors:  Piet Dirix; Sandra Nuyts; Vincent Vander Poorten; Pierre Delaere; Walter Van den Bogaert
Journal:  Support Care Cancer       Date:  2007-01-18       Impact factor: 3.603

2.  The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.

Authors:  K C M Leung; A S McMillan; M C M Wong; W K Leung; M Y Mok; C S Lau
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

Review 3.  Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.

Authors:  Laura S Sasportas; Drew N Hosford; Maria A Sodini; Dale J Waters; Elizabeth A Zambricki; Joëlle K Barral; Edward E Graves; Todd J Brinton; Paul G Yock; Quynh-Thu Le; Davud Sirjani
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-05-03

Review 4.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

Review 5.  Treatment of xerostomia and hyposalivation in the elderly: A systematic review.

Authors:  J-A Gil-Montoya; F-J Silvestre; R Barrios; J Silvestre-Rangil
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01

6.  Antimicrobial and Physicochemical Properties of Artificial Saliva Formulations Supplemented with Core-Shell Magnetic Nanoparticles.

Authors:  Katarzyna Niemirowicz-Laskowska; Joanna Mystkowska; Dawid Łysik; Sylwia Chmielewska; Grażyna Tokajuk; Iwona Misztalewska-Turkowicz; Agnieszka Z Wilczewska; Robert Bucki
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

7.  Saliva substitute mouthwash in nasopharyngeal cancer survivors with xerostomia: a randomized controlled trial.

Authors:  Dayaabaran Marimuthu; Kong Min Han; Mohd Shawal Firdaus Mohamad; Mawaddah Azman
Journal:  Clin Oral Investig       Date:  2020-11-11       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.